Larson Financial Group LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1731061 ST LOUIS, MO

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$110,210

+$66,421 QoQ

Shares Held

1,453

+120.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Larson Financial Group LLC holds $2,020,512 across 41 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	6,129	$724,509
2	NBIX	Neurocrine Biosciences Inc	1,542	$203,143
3	TAK	Takeda Pharmaceutical Co Ltd	7,759	$143,696
4	HIMS	Hims & Hers Health, Inc.	6,697	$139,029
5	HLN	Haleon plc	12,224	$122,362
6	LNTH	Lantheus Holdings, Inc. This page	1,453	$110,210
7	UTHR	UNITED THERAPEUTICS Corp	181	$107,329
8	HROW	Harrow, Inc.	2,277	$80,287

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$110,210	1,453	+120.8%	Shares	Sole	2026-05-15
2025-12-31	$43,789	658	+324.5%	Shares	Sole	2026-02-06
2025-09-30	$7,949	155	+93.8%	Shares	Sole	2025-11-14
2025-06-30	$6,548	80	+3900.0%	Shares	Sole	2025-08-08
2025-03-31	$195	2	+100.0%	Shares	Sole	2025-05-02
2024-12-31	$89	1	-99.5%	Shares	Sole	2025-02-07
2024-03-31	$12,448	200	0.0%	Shares	Sole	2024-05-03
2023-12-31	$12,400	200	+80.2%	Shares	Sole	2024-02-01
2023-09-30	$7,712	111	+11.0%	Shares	Sole	2023-11-03
2023-06-30	$8,392	100	-56.7%	Shares	Sole	2023-08-03
2022-06-30	$15,252	231	—	Shares	Sole	2022-08-04
No filing history on record for this holder in this stock.